(PhysOrg.com) -- Researchers in Taiwan have developed a new imaging contrast agent that will enable cancer patients to undergo CT and MRI scans on the same day, cutting diagnosis time in half.
(PhysOrg.com) -- Researchers in Taiwan have developed a new imaging contrast agent that will enable cancer patients to undergo CT and MRI scans on the same day, cutting diagnosis time in half.